LAURUS LABS LTD - stock earnings

LAURUSLABS.NS Quarterly earnings

DateEarningsRevenue
2023Q4 231.4 million INR 11.9 billion INR
2023Q3 369.5 million INR 12.2 billion INR
2023Q2 248.5 million INR 11.8 billion INR
2023Q1 1.0 billion INR 13.8 billion INR
2022Q4 2.0 billion INR 15.4 billion INR
2022Q3 2.3 billion INR 15.8 billion INR
2022Q2 2.5 billion INR 15.4 billion INR
2022Q1 2.5 billion INR 15.4 billion INR
2021Q4 1.5 billion INR 10.3 billion INR
2021Q3 2.0 billion INR 12.0 billion INR
2021Q2 2.4 billion INR 12.8 billion INR
2021Q1 3.0 billion INR 13.2 billion INR
2020Q4 2.7 billion INR 12.9 billion INR
2020Q3 2.4 billion INR 11.4 billion INR
2020Q2 1.7 billion INR 9.7 billion INR
2020Q1 1.1 billion INR 7.7 billion INR
2019Q4 734.8 million INR 7.3 billion INR
2019Q3 565.5 million INR 7.1 billion INR
2019Q2 151.0 million INR 5.5 billion INR
2019Q1 431.8 million INR 5.8 billion INR
2018Q4 178.2 million INR 5.3 billion INR
2018Q3 162.1 million INR 5.9 billion INR
2018Q2 165.6 million INR 5.4 billion INR
2018Q1 450.8 million INR 5.6 billion INR
2017Q4 348.7 million INR 4.8 billion INR
2017Q3 487.6 million INR 5.4 billion INR
2017Q2 389.1 million INR 4.8 billion INR
2017Q1 713.3 million INR 4.7 billion INR
2016Q4 450.2 million INR 5.1 billion INR
2016Q3 482.8 million INR 5.2 billion INR
2016Q2 256.4 million INR 4.1 billion INR

LAURUSLABS.NS Yearly earnings

DateEarningsRevenue
2023 7.9 billion INR 60.4 billion INR
2022 8.3 billion INR 48.9 billion INR
2021 9.8 billion INR 47.2 billion INR
2020 2.6 billion INR 27.6 billion INR
2019 937.6 million INR 22.4 billion INR
2018 1.7 billion INR 20.3 billion INR
2017 1.9 billion INR 18.7 billion INR
2016 1.3 billion INR 17.6 billion INR
2015 683.7 million INR 13.1 billion INR
2014 972.2 million INR 11.6 billion INR

LAURUSLABS.NS

Price: ₹440.15

52 week price:
306.50
471.00

Dividend Yield: 0.00%

5-year range yield:
0.00%
33.49%

Forward Dividend Yield: 0.36%

Payout Ratio: 46.38%

Payout Ratio Range:
23.53%
46.38%

Dividend Per Share: 1.60 INR

Earnings Per Share: 2.98 INR

P/E Ratio: 115.55

Exchange: NSI

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 235.8 billion

Average Dividend Frequency: 2

Years Paying Dividends: 7

DGR3: -4.35%

DGR5: 30.00%

Links: